NEWS & EVENTS
Company News
Press Release
For Immediate Release
July 8, 2009
Contact: Gregg DiPietro
Leerink Swann
(617) 918-4601
Gregg.DiPietro@leerink.com
Contact: Risa Burgess or Justin Drake
Schwartz Communications
(781) 684-0770
Leerink@schwartz-pr.com
LEERINK SWANN AND INTERPHARMALINK ESTABLISH GLOBAL COLLABORATION
Boston, MA, USA, Basel Switzerland, July 8, 2009- Healthcare-focused US investment bank Leerink Swann has formed a global collaboration with Swiss company InterPharmaLink.
Leerink Swann is a leading healthcare investment bank and specializes in equity research, corporate finance, strategic advisory and asset management services. InterPharmaLink is a leading provider of professional business development services to healthcare companies.
The collaboration enables Leerink Swann’s Strategic Advisory Group to access InterPharmaLink’s extensive network and business platform in Europe and Japan. The Strategic Advisory Group at Leerink Swann provides strategic advice to leading healthcare companies in areas including corporate strategy, therapeutic area strategy and specific product/device strategy.
InterPharmaLink will now have the ability to gain in-depth insight into the US healthcare market through Leerink Swann’s unique and powerful business platform.
”I am delighted about this partnership,” said Michael Jenkins, Senior Managing Director and Head of Leerink Swann Strategic Advisors. “InterPharmaLink’s Principals have an extensive network and perennial professional experience in the pharmaceutical world, particularly in Europe and Japan, which are highly attractive markets for us.”
Dr. Raimund Eckel, CEO of InterPharmaLink added, “Collaborating with a highly regarded and well known healthcare firm like Leerink Swann will enhance InterPharmaLink’s access to US healthcare companies and knowledge about the American pharma and biotech markets. This is a very important step for us and our global efforts in business development.”
About InterPharmaLink
InterPharmaLink is a leading provider of professional business development services to Pharma and Biotech companies. The company is transaction-oriented and helps its clients to create incremental value through Partnering and Mergers & Acquisitions on a global scale. InterPharmaLink’s Principals and Senior Advisors are experienced executives from within the pharmaceutical and management consulting industry. For more information, visit www.interpharmalink.com.
About Leerink Swann
Leerink Swann is a healthcare-focused investment banking firm that provides equity research, corporate finance, strategic advisory and asset management services for institutional, life sciences and high-net-worth clients. Every year since 2001, Institutional Investor has named Leerink Swann “Best of the Boutiques” in several healthcare categories. Through its MEDACorp division, Leerink Swann provides biomedical-consulting services to the institutional investment community. With an internal team of experts and a dedicated external network of academic and community healthcare professionals, MEDACorp assesses the viability of cutting-edge medical technologies, thus giving decision makers the information they need to perform. Leerink Swann is a member of FINRA/SIPC. For more information, visit www.leerink.com.